Mediscience Announces Pre-IDE Meeting Request for CD-Ratiometer

Mediscience Technology announced that its wholly owned New York subsidiary, Medi-Photonics Development, has requested a formal meeting with the FDA to discuss the CD-Ratiometer, an optical biopsy device as an adjunct to diagnosis for cancer detection of the cervix and other abnormalities. The submission of the pre-IDE (investigational device exemption) document was made by Schiff, a firm specializing in International regulatory affairs, compliance and clinical research.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050512005653&newsLang=en)